VitroNordic ApS: Financial statements 2025
CVR: 43795260
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
VitroNordic ApS (CVR 43795260) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 923,732 and a net result of DKK 268,144 compared with DKK 406,363 the year before. That is an increase of 20.6% compared with the year before. Equity in the 2025 report amounted to DKK 891,104. The solvency ratio was 51.1%.
- Gross Profit
- DKK 923,732
- Profit/Loss
- DKK 268,144
- Equity
- DKK 891,104
- Total Assets
- DKK 1,745,307
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 924 t. | 268 t. | 891 t. | 0 |
| 2024 | - | 766 t. | 406 t. | 623 t. | 1 |
| 2023 | - | 117 t. | -3 t. | 217 t. | 1 |
Official annual report
How creditworthy is VitroNordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
VitroNordic ApS has published its annual report for 2024. Gross profit came to DKK 765,789, and the net result was DKK 406,363.
About VitroNordic ApS
VitroNordic ApS is a Danish company of the type Anpartsselskab based in Hasselager, founded in 2023. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Lindhardsen. The company is owned by Future Life Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 923,732 and a net result of DKK 268,144 compared with DKK 406,363 the year before. Equity in the 2025 report amounted to DKK 891,104.